Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-03-01 @ 10:06 AM
Study NCT ID:
NCT03363334
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-08-01
First Post:
2017-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP
Sponsor:
Rigel Pharmaceuticals